HomeCompareBYCRF vs MRK

BYCRF vs MRK: Dividend Comparison 2026

BYCRF yields 2.34% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BYCRF wins by $129.60M in total portfolio value· pulled ahead in Year 2
10 years
BYCRF
BYCRF
● Live price
2.34%
Share price
$28.17
Annual div
$0.66
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$129.66M
Annual income
$119,838,014.62
Full BYCRF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — BYCRF vs MRK

📍 BYCRF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBYCRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BYCRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BYCRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BYCRF
Annual income on $10K today (after 15% tax)
$199.30/yr
After 10yr DRIP, annual income (after tax)
$101,862,312.43/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, BYCRF beats the other by $101,853,984.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BYCRF + MRK for your $10,000?

BYCRF: 50%MRK: 50%
100% MRK50/50100% BYCRF
Portfolio after 10yr
$64.86M
Annual income
$59,923,906.38/yr
Blended yield
92.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BYCRF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
18.3
Piotroski
9/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BYCRF buys
0
MRK buys
0
No recent congressional trades found for BYCRF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBYCRFMRK
Forward yield2.34%2.76%
Annual dividend / share$0.66$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$129.66M$56.8K
Annual income after 10y$119,838,014.62$9,798.13
Total dividends collected$128.89M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: BYCRF vs MRK ($10,000, DRIP)

YearBYCRF PortfolioBYCRF Income/yrMRK PortfolioMRK Income/yrGap
1$11,169$468.94$11,206$366.19$37.00MRK
2← crossover$12,930$978.98$12,650$502.35+$280.00BYCRF
3$15,953$2,118.35$14,407$694.19+$1.5KBYCRF
4$21,955$4,885.42$16,585$967.82+$5.4KBYCRF
5$36,059$12,567.26$19,342$1,363.89+$16.7KBYCRF
6$77,164$38,580.36$22,913$1,947.19+$54.3KBYCRF
7$236,880$154,314.91$27,662$2,823.89+$209.2KBYCRF
8$1,138,921$885,459.20$34,159$4,173.35+$1.10MBYCRF
9$9,176,196$7,957,550.16$43,337$6,308.80+$9.13MBYCRF
10$129,656,544$119,838,014.62$56,776$9,798.13+$129.60MBYCRF

BYCRF vs MRK: Complete Analysis 2026

BYCRFStock

BayCurrent Consulting, Inc. provides consulting services in Japan. The company provides engaged in designing and implementing strategy/business strategy, globalization, m&a/jv/alliances, innovation/new business development, turn-around, innovation/new business development, overseas expansion, global resource utilization, global governance design, change towards capturing inbound demand, marketing and sales strategy, and business due diligence.It offers DX-based high level planning, digital department launch, blockchain utilization, business model DX, designing thinking/agile operations, digital marketing, AI/IoT implementation, DX strategy/roadmap formulation, digital human resource development, fintech/insurtech, operation DX, and lean start-ups services. Additionally, the company provides procurement cost reduction, business process re-engineering, supply chain management, customer relationship management, risk management, value chain transformation, governance/management design, operation reform/standardization, and leadership training services. Further, it offers IT strategy, IT governance, IT cost optimization, IT organizational improvement, IT talent development, PMO, IT architecture, system design/ development, and IT asset evaluation services. The company serves financial, high-tech/telecommunication, media/entertainment, industrial/distribution/retail, health care, energy, and public sector industries. BayCurrent Consulting, Inc. was founded in 1998 and is based in Tokyo, Japan.

Full BYCRF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BYCRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BYCRF vs SCHDBYCRF vs JEPIBYCRF vs OBYCRF vs KOBYCRF vs MAINBYCRF vs JNJBYCRF vs ABBVBYCRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.